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Abstract
Background: Recombinant antibodies from Camelidae (VHHs) are potentially useful tools for
both basic research and biotechnological applications because of their small size, robustness, easy
handling and possibility to refold after chemio-physical denaturation. Their heat tolerance is a
particularly interesting feature because it has been recently related to both high yields during
recombinant expression and selective purification of folded protein.
Results: Purification of recombinant RE3 VHH by heat treatment yielded the same amount of
antibody as purification by affinity chromatography and negligible differences were found in stability,
secondary structure and functionality. Similar results were obtained using another class of
thermotolerant proteins, the single domain VH scaffold, described by Jespers et al. [8]. However,
thermosensitive VHs could not withstand the heat treatment and co-precipitated with the bacterial
proteins. In both cases, the thermotolerant proteins unfolded during the treatment but promptly
refolded when moved back to a compatible temperature.
Conclusion: Heat treatment can simplify the purification protocol of thermotolerant proteins as
well as remove any soluble aggregate. Since the re-folding capability after heat-induced
denaturation was previously correlated to higher performance during recombinant expression, a
unique heating step can be envisaged to screen constructs that can provide high yields of correctly-
folded proteins.
Background
There has been an increased interest in antibodies in
recent years, both because of their clinical applications
and their use in basic research [1]. Conventional antibod-
ies (mono- and poly-clonal) present several shortcom-
ings, such as their bulky structure, tedious and expensive
preparation, limited opportunities to introduce muta-
tions, and the immunogenic response they can induce
when used in therapy. For these reasons, a techniques
aimed at recombinant expression of antibodies selected
from both immunized and naïve/synthetic libraries can
be a convenient alternative [2].
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The most common format for antibody recombinant
expression is probably the single chain antibody (scFv), in
which the heavy and light variable regions are linked
together. Polybodies, with higher avidity for the antigen
than single scFv molecules, can be obtained by varying the
length of the linker or by connecting via a flexible hinge to
an amphipathic helix [3,4]. ScFvs have been widely used
to identify antigens in in vitro and in vivo experiments and
to deliver active molecules against tumor markers in
model animals [1].
The variable heavy (VHH) format is an alternative that
exploits the particularity of the Camelidae immunogenic
system. The animals belonging to this family possess,
beside antibodies of conventional structure, also antibod-
ies formed only by the heavy chain [5]. In this case all of
the information for the specific recognition of the antigen
is present in the heavy chain variable region. In contrast to
the variable heavy chain of conventional antibodies (VH),
which pairs with the light chain, the VHHs have evolved
in the absence of such a counterpart. This results in a
higher intrinsic stability of VHHs, in comparison to scFvs,
when the recombinant antibodies are expressed in bacte-
ria [6]. Since the paratope is mostly restricted to the
extruding CDR3 region, VHHs preferentially bind anti-
gens in small cavities otherwise not accessible to conven-
tional and scFv antibodies. For example, the active sites of
enzymes [7]. Furthermore, the ease in cloning and prepa-
ration of fusion constructs makes VHHs promising mole-
cules for biotechnological applications like antibody-
based microarrays and biosensors [5].
We wished to obtain stable recombinant antibodies for in
vitro and in vivo studies. However, several of the recom-
binant antibodies expressed in bacteria are structurally
unstable, signifying that good binders selected by phage
display cannot be successfully used for practical applica-
tions. Therefore, VHHs were first selected by phage dis-
play from an immune library (Olichon and Surrey,
unpublished data), and then an innovative approach
based on thermotolerance was used to investigate their
stability after recombinant expression.
Recently Jespers et al. [8] showed that thermotolerance of
VH domains correlated with their yields of recombinant
soluble protein. We were able to purify recombinant pro-
teins fused to Archaea partners by heating E. coli lysates
and to show that the treatment enabled, at the same time,
to select monodispersed proteins because aggregated
fusion proteins precipitated during the heat treatment [9].
VHHs are thermotolerant proteins and the results
reported in this paper show that a heating step can be used
to purify them and the VH domains, preserving their
structure and monodispersity.
Methods
Subcloning, expression, and purification of VHH and VH 
constructs
The VH constructs C36, C47, and DP47a were a kind gift
of Dr. Winter. The VHH RE3 was isolated by a phage dis-
play screen of a VHH immune library cloned into the
pHEN4 phagemid ([10]; Olichon, unpublished data). The
sequence corresponding to RE3 was subcloned into the
pHEN6 vector and this transformed into XL Blue compe-
tent cells. Transformed cells were used to inoculate Terrific
Brot. The culture was induced with 1 mM IPTG when the
OD600 reached 0.5 and grown overnight at 28°C. The pel-
let corresponding to a 1 L culture was recovered by centrif-
ugation and initially resuspended in 5 mL of TES buffer
(0.2 M TrisHCl, pH 8.0, 0.5 mM EDTA, 0.5 M sucrose)
before freezing in liquid nitrogen. It was then thawed on
ice and 5 mL TES plus 5× EDTA-free protease inhibitor
cocktail (Roche) were added. After 30 min incubation on
ice, osmotic shock was induced by supplementing the cell
suspension with 15 mL of 1:4 diluted TES buffer. After fur-
ther 30 min incubation on ice, the cells were centrifuged
20 min at 30,000 g and the supernatant was recovered.
NaCl and imidazole were added to a final concentration
of 250 mM and 10 mM, respectively, and the fraction was
purified by immobilized metal affinity chromatography
(IMAC) using a HiTrap Chelating column (Amersham)
and FPLC. The eluted fraction was desalted in 50 mM
TrisHCl, pH 8.0, 50 mM NaCl and 10% glycerol and
checked by SDS-PAGE. Its concentration was estimated
after measurement of the absorbance at 280 nm.
The gel filtration experiments were performed using a
Superpose 12 column (GE Healthcare) coupled to an
FPLC system.
Heat purification of both RE3 and VHs was performed by
heating the supernatants recovered after centrifugation of
the bacterial periplasmic fraction and adding of PEG 6000
(10% final volume). Samples were heated 15 min at 70°C
and thereafter cooled on ice for 20 min before pelleting
the denatured proteins [11]. Thermotolerant proteins
were recovered from the supernatant and analyzed by
SDS-PAGE.
An ELISA test was performed according to [12] using both
heat-treated and untreated RE3. A VHH directed against
lysozyme was used as a control. VHHs were detected using
an anti-His monoclonal antibody (Qiagen) and a second-
ary anti-mouse HRP conjugated antibody (Amersham).
Fluorimetric and CD analyses
The fluorimetric assay proposed by Nominé et al. [13] has
proved to be a reliable and simpler method than size
exclusion chromatography for estimating the aggregation
degree of proteins in solution [14]. It is the ratio betweenBMC Biotechnology 2007, 7:7 http://www.biomedcentral.com/1472-6750/7/7
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the adsorbance at 280 nm (light scattering due to soluble
aggregates) and that at 340 nm (specific absorbance of the
accessible aromatic groups). The measurements were per-
formed using an AB2 Luminescence Spectrometer
(Aminco Bowman). Samples were excited at 280 nm and
the emission spectra between 260 and 400 nm were
recorded.
Standard far-UV CD spectra of the recombinant antibod-
ies were recorded at 20°C using a Jasco J-710 spectropho-
tometer and cuvettes of 1 mm pathlength. 15 runs were
accumulated for each sample and three independent
repeats were performed to confirm the results. The spectra
of the unfolded proteins were determined after having
increased the temperature to 95°C using a Peltier heater
and those of the refolded proteins after a further incuba-
tion of 30 min at 20°C. Capped cuvettes were used to pre-
vent sample evaporation.
The wavelength for which the difference of ellipticity
value between the folded and unfolded states was maxi-
mum was selected for progressively heating the samples
and to identify the melting temperature (Tm) of the pro-
tein. The temperature was increased at a rate of 30°C/hour
from 15 to 95°C and the ellipticity values were recorded
at every increase of 0.2°C.
Results
Purification of the RE3 VHH binder
The RE3 binder was first selected after panning a llama
VHH phage display library using Ran-GTP, a protein
involved in mitotic spindle assembly. It was sub-cloned in
pHEN6 for expression in bacterial periplasm and showed
both high affinity and specificity in enzyme-linked immu-
nosorbant assay (ELISA) (Olichon, unpublished).
The first IMAC purifications resulted in a high yield of
recombinant VHH. A stability test was performed using
buffers at different pH and salt concentrations. The results
indicated that the stability of the RE3 VHH was strongly
salt dependent, since RE3 tends to polymerize and to form
progressively large aggregates in the absence of NaCl. The
polymerized forms were separated by SDS-PAGE in the
absence of fresh DTT (Fig. 1). The addition of 100 mM
NaCl was sufficient to prevent aggregation and to obtain
monomeric VHH (Fig. 1). It can be speculated that NaCl
prevents hydrophobic interactions favorable to the forma-
tion of intermolecular disulfide bonds. Using such condi-
tions, 8 mg of VHH were purified from 1 L culture, and the
low aggregation index indicated that the protein was
monodispersed. In the presence of NaCl, the VHH did not
aggregate even when kept at room temperature for several
days (data not shown).
Protein aggregates tend to precipitate faster than mono-
dispersed proteins when heated. Therefore, tolerance to
heat treatments has been proposed as a way to selectively
recover native proteins from a mixture in which aggregates
are present [9]. As an alternative to IMAC, RE3 was puri-
fied by heating the supernatant recovered after osmotic
shock of the bacterial cells for 15 min at 75°C. No signif-
icant differences in purity and yield were detected when
compared to the affinity purified VHH (Fig. 1). In addi-
tion, the binding efficiency of RE3 measured by ELISA was
not inhibited by the heat treatment (Fig. 2). Four further
llama VHHs were recovered monodispersed in the soluble
fraction after heat purification (data not shown), confirm-
ing that thermotolerance is not an exclusive feature of RE3
(See additional file 1).
Purification of the RE3 VHH recombinant antibody Figure 1
Purification of the RE3 VHH recombinant antibody. SDS 
PAGE and yields of RE3 purified by either IMAC or heat-
treatment, in the presence or absence of 100 mM NaCl.
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Purified RE3 was used to understand what structural mod-
ifications happen during heat treatment. Figure 3 shows
the CD spectra of the control protein (IMAC purified), the
protein heated 15 min at 75°C, and the same heat-treated
protein after 30 min on ice, indicating that VHH under-
went total denaturation during the heat treatment but
quickly refolded. Both gel filtration and the fluorimetric
analysis confirmed its monodispersed structure (Fig. 3).
The melting temperature for RE3 was determined using
the CD and calculated at 65.3°C.
These results confirm that the antibody was expressed in a
stable and native form in the bacterial periplasm and that
its native structure was preserved during affinity purifica-
tion and recovered after denaturation. However, its stabil-
ity and monodispersity were strictly dependent on salt
concentrations.
VH antibodies can be purified by heat treatment
Binders belonging to a specific class of VH antibodies [8]
have been shown to possess a large variability in their
capability to refold after heat denaturation. In particular,
the authors noticed a strong correlation between heat tol-
erance and yields of soluble antibodies expressed recom-
binantly in bacteria. We thought that it would be
interesting to compare the heat tolerance features of RE3
with those of the described VHs.
Stability of heat purified RE3 VHH Figure 3
Stability of heat purified RE3 VHH. A) CD spectra of IMAC and heat-treatment purified RE3. B) Gel filtration profiles and 
aggregation indexes of the same samples. The protein peaks corresponding to the IMAC and heat-purified RE3 (blue) are com-
pared to the profile of the molecular mass markers (red/pink).
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RE3 VHH binding capacity is not modified by heat treatment. 
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The heat tolerant VHs C36 and C47 as well as the heat sen-
sitive DP47a were expressed and purified from bacteria
periplasm. As expected, all three constructs were expressed
and a recognizable band was detectable in each total
lysate. However, only C36 and C47 were recovered solu-
ble in the supernatant after centrifugation (Fig. 4A). Since
phage displayed C47 refolded into an active structure after
heat denaturation [8], purification by IMAC and by heat
treatment were attempted. Similar yields of homogeneous
C47 were recovered using both of the purification proto-
cols (Fig. 4B).
The effect of the heat treatment was determined as
described above for VHH. The secondary structure of the
heat- and IMAC-purified C47 was analyzed by CD and the
aggregation of the two samples evaluated at the fluorime-
ter. No significant difference was detectable (aggregation
indexes of 0.12 and 0.14 for IMAC and heat-purified C47,
respectively; CD data in Fig. 5), indicating that heat puri-
fication of thermotolerant proteins may represent an
alternative to conventional affinity chromatography.
Discussion and conclusion
The data show that both C47 and RE3 can withstand heat
treatment. In particular, they are denatured but can cor-
rectly refold after heat denaturation and this feature ena-
bles their differential purification because the heating also
denatures and precipitates thermosensitive bacterial pro-
teins. The stability of RE3 seems to be dependent on the
conditions of the buffer, and NaCl is necessary to prevent
its progressive polymerization. Therefore, the robustness
of RE3 under optimal conditions does not implicate that
Purification of VH domain antibodies Figure 4
Purification of VH domain antibodies. A) Total lysates and soluble fractions obtained after periplasmic extraction of bacteria 
expressing the soluble VHs C36 and C47, as well as the insoluble VH DP47. B) Heat-treatment and affinity purification of C47. 
The supernatant obtained after periplasmic extraction was either heated 20 min at 70°C or loaded onto a cobalt-activated col-
umn for IMAC.
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VHH is easy to handle and negative results obtained in
some in vitro binding experiments might derive from its
instability under the experimental conditions. Recently, a
stable framework for the expression of VHH intrabodies
has been proposed and a grafting strategy was suggested to
transfer the CDR regions from any interesting but instable
Heat tolerance of the VH soluble domain C47 Figure 5
Heat tolerance of the VH soluble domain C47. The protein was denatured by a heat treatment (20 min × 70°C) and then left 
to recover 30 min on ice. CD spectra of native, heat-unfolded and refolded C47 were recovered and the aggregation indexes 
were measured at the fluorimeter.
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binder of the same HcAb subfamilly into such a structure
[15]. It would be useful to challenge this framework for its
buffer-tolerance as well, because the experience with RE3
clearly indicates that solubility and stability measured
under optimal conditions are misleading whenever the
application conditions significantly differ.
The original paper by G. Winter and co-workers indicates
that only heat-denatured VHs that could correctly refold
had structural features compatible with productive recom-
binant expression in bacteria [8]. Now we complete this
analysis by showing that not only the selection but even
the purification can be performed using a single heating
step. Therefore, the reported experiments enable an inter-
esting strategy for simplifying protein purification and
combining it with quality control [16]. Such a strategy is
based on the observation that not only the binding effi-
ciency of RE3 was not inhibited by a heat treatment (15
min at 75°C) sufficient to denature the bacterial proteins,
but other llama VHHs remained active after a heat treat-
ment at 90°C [6] or were able to bind their substrate at
70°C [17]. Similarly, the binding capacity of VHs is not
altered by a 10 min treatment at 80°C [8]. Furthermore,
the results of the present work confirm those of the recent
report showing that only monodispersed thermotolerant
proteins can withstand a heat treatment [9]. It also con-
firms that the heat-purified antibodies had the same sec-
ondary structure and low aggregation value typical of their
respective affinity purified antibodies. Therefore, we have
demonstrated that heat treatment can be applied for the
simultaneous purification and selection of native folded
and active proteins belonging to thermotolerant classes
such as VHs and VHHs (our study), as well as fusions with
Archaea proteins [9,11].
Heat purification is not only a fast and inexpensive alter-
native to conventional chromatography but, when appli-
cable, can also simplify the cloning strategy. Since no tag
is needed for affinity purification, it is not necessary to
produce tagged proteins that must be buffer exchanged,
digested and re-purified before, for instance, being used in
crystallography. The efficiency of heat purification with
regard to the possibility to eliminate the endotoxins from
bacterial recombinant protein preparations will be the
object of specifically dedicated experiments.
It seems that thermotolerance, defined as the capability to
refold after heat-denaturation, is sufficient for selective
heat-dependent protein recovery. However, whilst ther-
moresistance is a very peculiar feature of extremophiles,
thermotolerance can be identified even in proteins
expressed in thermosensitive organisms, as with VHs and
VHHs. We expect that other classes of thermotolerant pro-
teins will be identified or their thermotolerance specifi-
cally improved by the addition of suitable compatible
osmolytes [18].
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